Indonesia
Icon Cancer Centre (ID)

China
Icon Cancer Centre (CN)

Worldwide
Icon Group

- Helpful resources
- Understanding costs
- How to choose a specialist
- Becoming a patient
- Your care team
- Helpful cancer information
- Cancer guides
- Article library
- Patient stories
- Helpful details
- Support services
- Families and carers
- Life after cancer
- Get involved
Article title

John hits the road to celebrate the end of cancer treatment.
Articles
- Conditions
- More conditions
Article title

John hits the road to celebrate the end of cancer treatment
- Cancer treatments
- More treatments
CTA title

Sed aliquam tellus sit amet lectus suscipit molestie. Curabitur nec ultrices nunc, id feugiat nisi. Nam iaculis malesuada ex eget dictum.
CTA link
- Popular resources
- Understanding costs
- How to choose a specialist
- Becoming a patient
- Cancer information
- Cancer guides
- Cancer article library
- Patient stories
- Patients & families
- Support services
- For families and carers
- Life after cancer
Article title

John hits the road to celebrate the end of cancer treatment.
Read more
Doctors - test
Centres

Become a patient

Back
Home
Research
Find a trial

Find a trial

Find a clinical trial that suits you and your cancer diagnosis

Showing: Chun Loo Gan

SGNDV-001

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Locations Chermside

Diagnosis Urotherlial cancer

HERTHENA-PanTumor01 / U31402-277

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Locations Townsville, Hobart, Chermside

Diagnosis Advanced solid tumours

EIK1001-006

Safety and Efficacy of EIK1001-006 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma

Locations Chermside

Diagnosis Skin cancer – melanoma

DESTINY-BTC01 / D781PC00001

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Locations Chermside

Diagnosis Advanced solid tumours